Riskpilot← Back to searchSign inGet full accessRoyal-Skagen ApS
APSActiveCVR 42088927Allervej 130Processing and preserving of fish, crustaceans and molluscs · NACE 1020Est. 20216 employees
Revenue 2025
DKK 1,4M
-85% vs 2024
EBITDA margin
-96.7%
-124% vs 2024
Equity ratio
50.0%
Financial strength
Net profit 2025
DKK -1,8M
-145% vs 2024
| Revenue | DKK 1,4M | -85% |
| EBITDA | DKK -1,4M | -124% |
| Net profit | DKK -1,8M | -145% |
| Total assets | DKK 13,7M | -10% |
| Equity | DKK 6,8M | -21% |
| Employees | 6 | — |
Legal name
Royal-Skagen ApS
CVR number
42088927
Legal form
Anpartsselskab
NACE code
1020 · Processing and preserving of fish, crustaceans and molluscs
Founded
4. februar 2021
Share capital
DKK 50.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at eje og drive produktionsvirksomhed samt enhver aktivitet, som efter bestyrelsens skøn står i forbindelse hermed.
Address
Allervej 130
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.563 | 2.686 | 9.293 | 9.878 | 1.434 |
| Staff expenses | -1.386 | -2.153 | -2.623 | -3.984 | -2.821 |
| EBITDA | 177 | 533 | 6.668 | 5.893 | -1.387 |
| Depreciation & amort. | -236 | -277 | -478 | -611 | -755 |
| EBIT | -60 | 256 | 6.189 | 5.283 | -2.142 |
| Net financials | 23 | 48 | -614 | -99 | -180 |
| Profit before tax | -37 | 304 | 5.575 | 5.184 | -2.322 |
| Tax | -7 | 67 | 1.227 | 1.142 | -500 |
| Net profit | -30 | 237 | 4.349 | 4.042 | -1.822 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7.021 | 11.161 | 16.020 | 15.248 | 13.654 |
| Equity | 20 | 258 | 4.606 | 8.649 | 6.826 |
| Long-term debt | 5.677 | 625 | 1.052 | 927 | 802 |
| Short-term debt | 1.324 | 10.219 | 10.020 | 5.222 | 6.026 |
| Total debt | 7.000 | 10.844 | 11.072 | 6.149 | 6.828 |
EBITDA margin
-96.7%
This company
15.8%
Market median
-712% vs market
20212025
Equity ratio
50.0%
This company
38.2%
Market median
+31% vs market
20212025
Return on equity
-26.7%
This company
18.4%
Market median
-245% vs market
20212025
Net profit margin
-127.1%
This company
8.1%
Market median
-1669% vs market
20212025
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20212025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-02-04 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TC Management | Management | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2021 | |
| Company | 50–66.65% | 50–66.65% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ejendommelig ApS
Royal-Skagen ApS Board members of Royal-Skagen ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Christian Rask | Management | 0 companies |
| Christian Christensen | Chairman | 0 companies |
| Hans Erik Bylling | Board of Directors | 0 companies |